Compare INDB & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INDB | LIVN |
|---|---|---|
| Founded | 1907 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.5B |
| IPO Year | 1994 | 2015 |
| Metric | INDB | LIVN |
|---|---|---|
| Price | $80.06 | $70.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $74.50 | $70.25 |
| AVG Volume (30 Days) | 275.2K | ★ 796.7K |
| Earning Date | 04-23-2026 | 06-01-2026 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.44 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $33.83 | $8.14 |
| Revenue Next Year | $5.85 | $6.53 |
| P/E Ratio | $27.07 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $52.15 | $32.48 |
| 52 Week High | $87.00 | $71.58 |
| Indicator | INDB | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 47.13 | 67.09 |
| Support Level | $78.54 | $61.50 |
| Resistance Level | $87.00 | N/A |
| Average True Range (ATR) | 2.72 | 2.33 |
| MACD | -0.72 | 0.30 |
| Stochastic Oscillator | 35.29 | 86.97 |
Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.